thomas mckee
Université de Genève
H-index: 32
Europe-Switzerland
Top articles of thomas mckee
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer
JCO Precision Oncology
2024/3
PO009/# 424 Innovative academic homologous recombination deficiency tests available in advanced ovarian cancer: the European ENGOT initiative
2023/11/1
Effectiveness of Fractionated Rituximab in Preventing Tumor Lysis Syndrome in Aggressive B-Cell Lymphoma: Insights from Real-Life Clinical Practice
Authorea Preprints
2023/10/9
Thomas Mckee
H-Index: 18
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Science
2023/8/4
3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness
Matrix Biology
2023/6/1
Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma
JCO Precision Oncology
2023/6
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
Journal of Experimental & Clinical Cancer Research
2023/4/3
1275 Mapping the heterogeneous colorectal tumor microenvironment with multiplexed imaging and machine learning
2022/11/1
2022-RA-567-ESGO The Geneva HRD test: clinical validation on 469 samples from the PAOLA-1 trial
2022/10/1
FOLFOXIRI resistance induction and characterization in human colorectal cancer Cells
Cancers
2022/9/30
Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland
BMJ open
2022/8/1
Thomas Mckee
H-Index: 18
Thomas Zilli
H-Index: 20
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer
BMC cancer
2022/7/15
Thomas Mckee
H-Index: 18
Thomas Zilli
H-Index: 20
727 HRD scoring with a SNP assay
International Journal of Gynecological Cancer
2021/10/1
201 Homologous recombination deficiency testing in advanced ovarian cancer: description of the ENGOT HRD European initiative
2021/10/1
Targeting OLFML3 in colorectal cancer suppresses tumor growth and angiogenesis, and increases the efficacy of anti-PD1 based immunotherapy
Cancers
2021/9/15
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab
Gynecologic Oncology Reports
2021/8/1
Use of Diagnostic Algorithms for NTRK Fusion-Positive Tumors in Pathology Institutes in Switzerland
healthbook TIMES Oncology Hematology
2021/3/9
Unmasking viral sequences in human blood samples during graft-versus-host disease
2021/2/25
Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma
Transplantation
2021/2/1
Automated detection of arm-level alterations for individual cancer patients in the clinical setting
The Journal of Molecular Diagnostics
2021/12/1